TREATMENT OF HEMATOLOGICAL MALIGNANCY WITH SMALL MOLECULE NF-KB INHIBITORS

摘要

The disclosure relates to compounds and compositions that inhibit NF-κB and are useful in the treatment of hematological malignancies such as lymphoma and myeloma.